Ideating on Glooko’s existing EndoTool system, the cloud-based version is designed to support more scalable deployment across hospital settings.

Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.

BlueWind plans to use the funds for expanding sales functions and market access initiatives for its Revi implantable tibial neuromodulation system.

Ardent Health and Fujifilm Healthcare are to bring Synapse enterprise imaging solutions to its acute care hospitals across six US states.

During a presentation at the J.P. Morgan Healthcare Conference 2026, Boston Scientific indicated a population of over 10 million atrial fibrillation patients in the ...

Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device for BPH.

Revvity has received FDA clearance for its total testosterone automated ChLIA via its Immunodiagnostic Systems subsidiary.

UroMems plans to use the funds to complete a pivotal trial to support regulatory filings for its UroActive system in the US and Europe.

AngioDynamics has reported two-year data from the PRESERVE pivotal trial, showing durable outcomes for the NanoKnife IRE system in treating intermediate-risk prostate cancer.